Dago, M.; Crespo-García, T.; Cámara-Checa, A.; Rapún, J.; Rubio-Alarcón, M.; Marín, M.; Tamargo, J.; Caballero, R.; Delpón, E.
Empagliflozin and Dapagliflozin Increase Na+ and Inward Rectifier K+ Current Densities in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells (hiPSC-CMs). Cells 2022, 11, 3707.
https://doi.org/10.3390/cells11233707
AMA Style
Dago M, Crespo-García T, Cámara-Checa A, Rapún J, Rubio-Alarcón M, Marín M, Tamargo J, Caballero R, Delpón E.
Empagliflozin and Dapagliflozin Increase Na+ and Inward Rectifier K+ Current Densities in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells (hiPSC-CMs). Cells. 2022; 11(23):3707.
https://doi.org/10.3390/cells11233707
Chicago/Turabian Style
Dago, María, Teresa Crespo-García, Anabel Cámara-Checa, Josu Rapún, Marcos Rubio-Alarcón, María Marín, Juan Tamargo, Ricardo Caballero, and Eva Delpón.
2022. "Empagliflozin and Dapagliflozin Increase Na+ and Inward Rectifier K+ Current Densities in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells (hiPSC-CMs)" Cells 11, no. 23: 3707.
https://doi.org/10.3390/cells11233707
APA Style
Dago, M., Crespo-García, T., Cámara-Checa, A., Rapún, J., Rubio-Alarcón, M., Marín, M., Tamargo, J., Caballero, R., & Delpón, E.
(2022). Empagliflozin and Dapagliflozin Increase Na+ and Inward Rectifier K+ Current Densities in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells (hiPSC-CMs). Cells, 11(23), 3707.
https://doi.org/10.3390/cells11233707
